Literature DB >> 4197367

[Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].

C Aiello, D Turner, N J Aparicio, E A De Turner, A Vazquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197367     DOI： 10.1007/bf02590651

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  8 in total

1.  A simplified method for immuno-assay of human serum insulin.

Authors:  R C MEADE; H M KLITGAARD
Journal:  J Nucl Med       Date:  1962-09       Impact factor: 10.057

2.  Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.

Authors:  E Cerasi; R Luft; S Efendic
Journal:  Diabetes       Date:  1972-04       Impact factor: 9.461

3.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

Authors:  P C Chu; M J Conway; H A Krouse; C J Goodner
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

4.  Evidence that glucose load is an important determinant of plasma insulin response in normal subjects.

Authors:  D T Peterson; G M Reaven
Journal:  Diabetes       Date:  1971-11       Impact factor: 9.461

5.  Study of the relationship between glucose and insulin responses to an oral glucose load in man.

Authors:  G Reaven; R Miller
Journal:  Diabetes       Date:  1968-09       Impact factor: 9.461

6.  Plasma insulin and metabolic study on diabetes treated with glibenclamide.

Authors:  J Anderson; R Coulson; B D Grassick; B A Morris; W D Thomas; R W Tomlinson; F Woodroffe
Journal:  Postgrad Med J       Date:  1970-12       Impact factor: 2.401

7.  Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.

Authors:  G Reaven; J Dray
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

8.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461
  8 in total
  2 in total

1.  Trial of placebo in long-term chlorpropamide-treated diabetics.

Authors:  A Lev-Ran
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

2.  Behaviour of glibenclamide on repeated administration to diabetic patients.

Authors:  L Balant; G R Zahnd; F Weber; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.